| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00060996 Details | 2013-03-07 Interventional | 3 | - | Treprostinil Chronic Limb-Th… Foot Ulcer Ischemia Peripheral Arte… Peripheral Vasc… Vascular Diseas… Critical Limb I… Foot Ulcers Peripheral Vasc… Rest Leg Pain | - - | |||
| NCT01279291 Details | 2013-03-06 Interventional | 1 | 22 | Carboplatin Doxorubicin Gemcitabine Liposomal doxor… Paclitaxel Carcinoma, Ovar… Fallopian Tube … Neoplasms Ovarian Neoplas… Peritoneal Neop… Primary Periton… | The study was stopped due to the inability to determine an acceptable dose with the potential
for further study - | |||
| NCT01111682 Details | 2013-03-05 Interventional | 3 | 5 | Mannitol Brain Injuries Brain Injuries,… Intracranial Hy… Elevated Intrac… Traumatic Brain… | A significant reduction in head injuries coupled with more frequent use of crainectomy reduced
the number of potential subjects. - | |||
| NCT00950820 Details | 2013-03-04 Interventional | 2 | 9 | Capecitabine Oxaliplatin Panitumumab Colorectal Neop… | Recruitment rate to low; changed environment made protocol in its current state obsolete - | |||
| NCT00889343 Details | 2013-03-04 Interventional | 2 | 101 | Fluorouracil Irinotecan Leucovorin Oxaliplatin Sorafenib Colorectal Neop… | - - | |||
| NCT00870441 Details | 2013-02-28 Interventional | 1 | 442 | Valacyclovir Safety of ASP21… | Study terminated due to treatment-emergent serious adverse events - | |||
| NCT00820612 Details | 2013-02-28 Interventional | 4 | 602 | Indomethacin Pancreatitis Post-ERCP Pancr… | Stopped by DSMB for overwhelming benefit of indomethacin (unethical to withhold indomethacin
from patients) - | |||
| NCT01658358 Details | 2013-02-27 Interventional | 1/2 | - | Doxorubicin Lapatinib Liposomal doxor… Breast Neoplasm… Metastatic Brea… | - - | |||
| NCT01016054 Details | 2013-02-27 Interventional | 1 | 4 | Carboplatin Doxorubicin Gemcitabine Liposomal doxor… Carcinoma, Ovar… Ovarian Disease… Ovarian Neoplas… Carcinoma Ovarian Cancer | Trial was terminated to allow sponsors to evaluate the future development of the drug program - | |||
| NCT01798602 Details | 2013-02-26 Interventional | 2 | 8 | Rosuvastatin Ca… H1N1 Influenza | H1N1 pandemic concluded - | |||
| NCT01223755 2007-005047-21 Details | 2013-02-25 Interventional | 2/3 | 41 | Sirolimus Arthrogryposis Kidney Diseases Polycystic Kidn… Polycystic Kidn… Renal Insuffici… Autosomal Domin… | safety and efficacy reason - | |||
| NCT00696787 Details | 2013-02-25 Interventional | 2 | 125 | Desvenlafaxine … Pregabalin Fibromyalgia Myofascial Pain… | - - | |||
| NCT01058408 Details | 2013-02-22 Interventional | 1 | 3 | Cisplatin Everolimus Head and Neck N… Head and Neck C… | - - | |||
| NCT00959946 Details | 2013-02-22 Interventional | 1/2 | 32 | Bosutinib Capecitabine Breast Neoplasm… Cholangiocarcin… Glioblastoma Advanced Breast… Advanced Cholan… Advanced Colore… Advanced Gliobl… Advanced Pancre… | - Results are not provided because the study was terminated prior to part 2 due to unfavorable risk benefit ratio of the study treatment. | |||
| NCT00744250 Details | 2013-02-22 Interventional | 4 | 3 | Pancreatin Pancrelipase Cystic Fibrosis Exocrine Pancre… Fibrosis Pancreatitis Pancreatitis, C… Chronic Pancrea… | No longer required study by FDA for NDA approval. - | |||
| NCT01142128 Details | 2013-02-21 Interventional | 1 | 12 | Esomeprazole Pancreatin Pancrelipase Pancreatitis Pancreatitis, C… Chronic Pancrea… | Viokase was taken off market during study and remained off over a year. - | |||
| NCT01033955 Details | 2013-02-21 Interventional | 2 | 8 | Rosuvastatin Ca… Critical Illnes… Infections Influenza, Huma… Critically Ill H1N1/Influenza … | H1N1 pandemic concluded in early 2010 - | |||
| NCT01680796 Details | 2013-02-20 Interventional | 1 | 0 | Bortezomib Dexamethasone Multiple Myelom… Neoplasms, Plas… | The target drug, dovitinib, failed as a single agent in prior studies in patients with heavily
treated multiple myeloma. - | |||
| NCT00531115 2006-007062-11 Details | 2013-02-20 Interventional | 2 | 28 | Cetuximab Colorectal Neop… Metastatic Colo… | According to the study design, in the first step the number of responses was lower than the
number required (< 7). - | |||
| NCT00433953 Details | 2013-02-20 Interventional | 1 | 44 | Mycophenolic Ac… Kidney Transpla… | No longer following patient and no plans to publish. - |